SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is trending as investors highlight its ultra-low circulating supply and small market cap as key catalysts for significant potential upside. The community is actively discussing the possibility of a major price breakout, with many drawing comparisons to previous market cycles and pinning hopes on upcoming exchange listings or an broader resurgence in the NFT sector.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for the community due to renewed institutional interest and a wave of activity surrounding its potential in real-world asset (RWA) tokenization and post-quantum security research. Investors are actively debating the long-term viability of the project, weighing concerns over its historical price performance against optimism that new governance developments and potential regulatory clarity will drive future utility.

BENQI is a decentralized non-custodial liquidity market protocol, built on Avalanche. The protocol enables users to effortlessly lend, borrow, and earn interest with their digital assets. Depositors providing liquidity to the protocol may earn passive income, while borrowers are able to borrow in an over-collateralized manner.

Benqi Finance

Benqi Finance is seeing significant community discussion driven by its status as a major DeFi project on the Avalanche network, with investors closely watching its total value locked and potential for real-world asset integration. While some holders express frustration over recent price volatility and accumulation struggles, many participants remain optimistic about its long-term utility and ecosystem growth alongside AVAX.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DebtReliefBot (DRB) is generating significant community excitement due to its unique ties to AI-driven token creation and its association with the Grok ecosystem, which users highlight for its substantial fee accumulation. Investors are closely monitoring the project for its low market cap and perceived early-stage potential within the Base ecosystem, often discussing it alongside the BNKR token as a key AI-to-AI innovation.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending as investors monitor the company's $50 billion infrastructure plan and potential growth from surging data center power demand, while sentiment remains weighed by regulatory uncertainties and the impact of federal policy on its major offshore wind initiatives. The community is actively debating the company's valuation against its dividend yield and long-term execution risks as it attempts to balance renewable investments with core utility performance.

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals is currently trending due to its recent FDA approval for DESMODA, a milestone that community members view as a significant step in the company's evolution from a biotech hopeful to a revenue-generating commercial player. The community is actively discussing the stock's potential as an undervalued "hidden gem," citing strong recent financial performance, successful portfolio expansion, and an upcoming earnings report as key drivers for potential long-term growth.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is seeing heightened trader attention as the community debates its potential as a high-performance Layer 1 alternative to established networks like Ethereum and Solana. Discussions are currently dominated by a mix of long-term optimism regarding its ecosystem growth and staking utility versus concerns over recent price volatility and token distribution schedules.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips is currently attracting significant attention as investors react to a planned 20-25% reduction in its global workforce, a move widely interpreted as a cost-cutting measure to prepare for a lower oil price environment. The community is actively debating the stock's future amid this restructuring, with many investors weighing the company's long-term operational resilience against broader sector headwinds and ongoing volatility in commodity markets.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors rally around the company's upcoming May 31 PDUFA date for its ADHD candidate, CTx-1301, while closely monitoring expectations for imminent U.S. patent approval. The community is actively discussing the stock's potential for significant upside based on its low float and the massive market opportunity for its precision-timed drug delivery platform.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently a major focus for traders as the community debates the impact of a newly launched spot ETF against persistent price volatility and broader regulatory uncertainty. Investors are actively discussing the token's long-term utility in institutional RWA tokenization, with sentiment split between those accumulating at current price levels and those frustrated by the asset's recent performance compared to market benchmarks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AI and Biotech Enter a Stock Picker’s Market

The market is sending a mixed but telling signal: innovation is accelerating, but only the most disciplined and well-positioned companies are keeping pace. Across AI, biotech, and micro-cap tech, recent developments highlight a widening divide between firms gaining validation and those fighting to maintain footing in public markets. $BFRG, $TGNT, $LTRN, $VRAX, $KIDZ, $HKIT

<ul class="summary-bullets"><li>Artelo Biosciences shares gained more than 23% before the opening bell on Tuesday after the company announced the closure of its $11 million private placement of common stock.</li><li>Bullfrog AI shares soared more than 12% in Tuesday’s pre-market trade, building on the gains of 107% on Monday after the company announced an agreement with a major global pharmaceutical company.</li><li>Hitek Global shares more than doubled in Tuesday’s pre-market trade, soaring 110% as the company’s $3 million registered direct offering of Class A ordinary shares closed on Monday.</li></ul>U.S. equities were in the green in Tuesday’s pre-market trade after President Donald Trump reportedly indicated that he would be willing to end the Iran war without a complete reopening of the Strait of Hormuz.According to a report by The Wall Street Journal, President Trump told his aides about his willingness to end the war without getting Iran to reopen the strait following an assessment that this mission would result in prolonging the conflict beyond the four to six-week timeline.At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was up 0.92%; the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) rose 0.86%; and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) gained 0.94%. Retail sentiment on Stocktwits regarding the S&amp;P 500 ETF was in the ‘extremely bearish’ territory.<h2 class="st-heading-2">Here are the top stocks making the biggest moves in Tuesday’s pre-market trade:</h2><a href="https://stocktwits.com/symbol/ARTL">Artelo Biosciences Inc. (ARTL)</a>Artelo Biosciences shares gained more than 23% before the opening bell on Tuesday after the company announced the closure of its $11 million private placement of common stock. Artelo stated that it intends to use the proceeds to repay a bridge debt and meet working capital requirements.<a href="https://stocktwits.com/symbol/ARTL">ARTL stock</a> is up 139% year-to-date.<a href="https://stocktwits.com/symbol/BFRG">Bullfrog AI Holdings Inc. (BFRG)</a>Bullfrog AI shares soared more than 12% in Tuesday’s pre-market trade, building on the gains of 107% on Monday after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bfrg-stock-more-than-doubled-today-what-is-fueling-the-surge/cZERFnXRIZz">announced</a> an agreement with a major global pharmaceutical company to accelerate its drug discovery and clinical development programs.<a href="https://stocktwits.com/symbol/BFRG">BFRG stock</a> is up 19% year-to-date.<a href="https://stocktwits.com/symbol/HKIT">Hitek Global Inc. (HKIT)</a>Hitek Global shares more than doubled in Tuesday’s pre-market trade, soaring 110% as the company’s $3 million registered direct offering of Class A ordinary shares closed on Monday.<a href="https://stocktwits.com/symbol/HKIT">HKIT stock</a> is down 98% year to date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/jerome-powell-fed-iran-war-effects-not-facing-policy-decision-yet/cZERs6iRIN9">Powell Says Fed ‘Not Really Facing’ Policy Decision Yet Amid Iran Oil Shock – Adds Central Bank Will Be ‘Mindful Of The Broader Context’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ARTL, BFRG, HKIT Among Stocks Soaring Before The Bell — Top Pre-Market Gainers Today

U.S. equities gained in Tuesday’s pre-market trade after President Donald Trump reportedly stated that the Iran war could be ended without a full reopening of the Strait of Hormuz.

Equity

The Boom Enters New Phase

The artificial intelligence boom is entering a new phase, one defined less by infrastructure and more by real-world application. Nowhere is that shift more visible than in biotech, where data, diagnostics, and drug discovery are converging into a high-stakes innovation race. Recent developments across public markets show both the promise and the volatility of this transition, as capital flows toward platforms capable of turning complex biological data into actionable outcomes. $KBLB, $BFRG, $RZLV, $ELAB, $EEIQ, $ITRM

Legendary Investors are Rotating Capital into AI-Powered Biotech

Cathie Wood and ARK Invest are making a decisive pivot that signals where the next phase of artificial intelligence value creation may emerge: healthcare. In a series of trades during late March, Wood aggressively reduced exposure to mega-cap technology and semiconductor names while building a high-conviction position in Tempus AI (NASDAQ:TEM). The move reflects a broader thesis she has increasingly emphasized: the most underestimated frontier for AI innovation is healthcare. As AI infrastructure becomes crowded and capital-intensive, ARK is rotating toward companies applying AI to real-world, high-stakes problems like disease detection, drug development, and clinical decision-making. $ROKU, $NVDA, $TSM, $TSLA, $BFRG, $TGNT

<ul class="summary-bullets"><li>Bullfrog AI CEO Vin Singh stated that the agreement the company struck is a validation of its capabilities.</li><li>He remains confident that Bullfrog’s relationship with the pharmaceutical company will expand to other areas of its research and development portfolio.</li><li>Bullfrog uses AI with its bfLEAP, bfPREP, and bfARENAS platforms to provide developers with a path to discover and characterize drug targets for diseases like major depressive disorder.</li></ul>Bullfrog AI Holdings Inc. (BFRG) shares gained more than 152% in Monday’s opening trade after the company announced a deal with a major global pharmaceutical giant.Bullfrog AI stated that its agreement requires the company to use its bfLEAP program to identify and prioritize novel drug targets in major depressive disorder (MDD). The company stated that this is aimed at accelerating its drug discovery and clinical development programs.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/BFRG">Bullfrog AI</a> trended in the ‘extremely bullish’ territory with message volumes at ‘high’ levels at the time of writing.<h2 class="st-heading-2">Agreement Is A Validation Of Bullfrog’s Capabilities, Says CEO</h2>Bullfrog AI CEO Vin Singh stated that the agreement the company struck is a validation of its capabilities.“Our bfLEAP, bfPREP, and bfARENAS integrated platform leverages causal network inference to provide drug developers a clearer path forward in the discovery and characterization of drug targets for a complex disease like MDD,” Singh added. He remains confident that Bullfrog’s relationship with the pharmaceutical company will expand to other areas of its research and development portfolio.MDD is a mental health condition that is characterized by a loss of interest in activities or persistent and intense sadness. It is also called clinical or unipolar depression.The company stated that data from Stellar Market Research shows that the MDD market was valued at more than $8 billion in 2025 and is expected to reach $11 billion by 2032.<h2 class="st-heading-2">What Does Bullfrog AI Do?</h2>Bullfrog AI is a Gaithersburg, Maryland-based company that uses artificial intelligence and machine learning to advance drug discovery and development.The company stated that it uses AI in combination with its bfLEAP platform to analyze complex biological data, aiming to accelerate drug development and reduce clinical trial failure rates.<a href="https://stocktwits.com/symbol/BFRG">BFRG stock</a> is up 31% year-to-date, but down 32% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 15% over the past 12 months, while the Vanguard Extended Market Index Fund ETF (VXF) is up 16%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-vrdn-stock-falling-today/cZERVHrRIZD">VRDN Stock Plummeted 41% Pre-Market Today — What Did Its Phase 3 Active Thyroid Eye Disease Trial Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

BFRG Stock More Than Doubled Today — What Is Fueling The Surge?

Bullfrog AI announced an agreement with a major global pharmaceutical company to accelerate its drug discovery and clinical development programs.

BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company was founded by Vininder Singh in August 2017 and is headquartered in Gaithersburg, MD.

Bullfrog AI Holdings Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$1.20
Prev Close	$1.62
Open	$1.50
Dividend Yield	0.00%
50-Day Moving Average	$0.6498
Beta	2.18
Avg. Volume	28.08M
PE Ratio	-1.89

52-Week High	$2.20
52-Week Low	$0.4251
Market Capitalization	$15.2M
EPS (Annual)	-$0.6286
Price to Book	6.41
Revenue Per Employee	$12,963.33

BFRG
Bullfrog AI Holdings, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BFRG News

BFRGBullfrog AI Holdings, Inc.